Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St slips as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Bloom Energy shares fall on Oracle project halt
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
Constellation Pharmaceuticals (CNST) Halted Again, Now Up 156%
November 6, 2019 10:14 AM ESTConstellation Pharmaceuticals (NASDAQ: CNST) Halted Again, Now Up 156%
... MoreConstellation Pharmaceuticals (CNST) Halted Again, Up 113%
November 6, 2019 10:08 AM ESTConstellation Pharmaceuticals (NASDAQ: CNST) Halted Again, Up 113%
... MoreConstellation Pharmaceuticals (CNST) Halted on Second LUDP, Up 80%
November 6, 2019 9:58 AM ESTConstellation Pharmaceuticals (NASDAQ: CNST) Halted on Second LUDP, Up 80%
... More